{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Clinical Lab Chat","title":"From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/659300df\"></iframe>","width":"100%","height":180,"duration":1275,"description":"In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).\n \nThe wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including:\nWhy traditional methods of Alzheimer’s testing are expensive, invasive, and limit access.\nThe benefits of blood-based biomarkers for Alzheimer’s diagnosis.\nHow better diagnostics will benefit patients.\nWhy we’re on the cusp of a new golden age of neurology\nHow more biomarkers fuel not only better diagnostics but better treatments.","thumbnail_url":"https://img.transistorcdn.com/tufk3X-Gxx2xn3K2zoupAtyj7GTQZyUUKf-riXddPoM/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQ0MzA4LzE2OTQw/OTgxOTctYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}